However, another study that compared the rate of prevalence of BRCA1 and BRCA2 PGVs in patients with lung adenocarcinoma with ATM PGVs reported a higher prevalence of BRCA1 and BRCA2 PGVs [29]. The gene discussed is BRCA2; the disease is lung adenocarcinoma.